A carregar...
Synergistic Anti-Tumor Activity of EZH2 Inhibitors and Glucocorticoid Receptor Agonists in Models of Germinal Center Non-Hodgkin Lymphomas
Patients with non-Hodgkin lymphoma (NHL) are treated today with a cocktail of drugs referred to as CHOP (Cyclophosphamide, Hydroxyldaunorubicin, Oncovin, and Prednisone). Subsets of patients with NHL of germinal center origin bear oncogenic mutations in the EZH2 histone methyltransferase. Clinical t...
Na minha lista:
Publicado no: | PLoS One |
---|---|
Main Authors: | , , , , , , , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Public Library of Science
2014
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4262195/ https://ncbi.nlm.nih.gov/pubmed/25493630 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0111840 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|